Date: 2012-05-16
Type of information: Distribution agreement
Compound: SmartGene HIV-1 Starter Module
Company: Siemens Healthcare Diagnostics France (France) SmartGene (Switzerland)
Therapeutic area: Infectious diseases
Type agreement: distribution
Action mechanism: SmartGene HIV provides up-to-date, online interpretation for HIV genotyping and analysis of resistance patterns. The service supports multiple targets (for example, protease, RT, integrase, gp41, gp120 (v3), and gag), and uses the latest versions of various interpretive algorithms. Integrated and automated functions support rapid and reliable editing of chromatograms, automatic determination of mutations, and identification of HIV drug resistance patterns. V3 loop sequences are easily mapped and extracted for tropism analysis.
Disease: HIV-Aids
Details: Siemens Healthcare Diagnostics France and SmartGene have signed a distribution agreement under which Siemens will distribute into the French market the SmartGene HIV-1 Starter Module. Under this agreement SmartGene has adapted its established HIV service module for the needs of molecular biology laboratories equipped with the TRUGENE® HIV-1 genotyping system from Siemens.
Financial terms:
Latest news:
